Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-23

Clinical Trial Update: Fulvestrant in Metastatic Breast Cancer [Phase 4]

View source ↗

Summary

An update on a Phase 4 trial evaluating fulvestrant in metastatic breast cancer. The current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fulvestrant (fulvestrant)

Snippet

Sponsor: Assiut University | Conditions: Metastatic Breast Cancer | Phase 4 | Status: UNKNOWN